logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

Jiangsu Hengrui Pharmaceuticals (01276) repurchased 60,000 A shares for RMB 2.6965 million on October 14.

date
16:43 14/10/2026
avatar
GMT Eight
Jiangsu Hengrui Pharmaceuticals (01276) announced that on October 14, 2026, it repurchased 60,000 A shares for RMB 2.6965 million.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on October 14, 2026, it repurchased 60,000 A shares for RMB 2.6965 million.
Related Articles
HK Stock
TECHTRONIC IND (00669) repurchased 88,000 shares for HK$11.3357 million on October 14.
HK Stock
ZHONGYU ENERGY (03633) repurchased 400,000 shares for HK$1.0663 million on October 14.
China Stock
Zhejiang Conba Pharmaceutical (600572.SH): Zhejiang Conba Pharmaceutical Group plans to reduce its shareholding by no more than 1%.
TECHTRONIC IND (00669) repurchased 88,000 shares for HK$11.3357 million on October 14.
HK Stock
ZHONGYU ENERGY (03633) repurchased 400,000 shares for HK$1.0663 million on October 14.
HK Stock
Zhejiang Conba Pharmaceutical (600572.SH): Zhejiang Conba Pharmaceutical Group plans to reduce its shareholding by no more than 1%.
China Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.